Table 4.

GRADE test accuracy evidence summary for using a platelet-dependent VWF activity assay/VWF:Ag ratio < 0.6 to diagnose type 1 VWD

OutcomeStudies/ patientsStudy designFactors that may decrease CoEEffect per 1000 patients tested; pretest probability of 30%Test accuracy CoE
Risk of biasIndirectnessInconsistencyImprecisionPublication bias
True positives* 3/97 Cohort and case-control type Serious Not serious Serious Serious§ None 203-291 ⨁◯◯◯
Very low 
False negatives 9-97 
True negativesǁ 1/87 Cohort and case-control type Serious Not serious Not serious Serious None 612 ⨁⨁◯◯
Low 
False positives# 88 
OutcomeStudies/ patientsStudy designFactors that may decrease CoEEffect per 1000 patients tested; pretest probability of 30%Test accuracy CoE
Risk of biasIndirectnessInconsistencyImprecisionPublication bias
True positives* 3/97 Cohort and case-control type Serious Not serious Serious Serious§ None 203-291 ⨁◯◯◯
Very low 
False negatives 9-97 
True negativesǁ 1/87 Cohort and case-control type Serious Not serious Not serious Serious None 612 ⨁⨁◯◯
Low 
False positives# 88 

Sensitivity, 0.68-0.97, specificity, 0.87-0.88.

Prevalences are 30%; typically seen in patients investigated for type 2 VWD because of a low VWF:RCo/Ag ratio.

CoE, certainty of the evidence.

*

Patients with type 2 VWD.

Serious patient selection risk of bias due to the case-control design. Also, issues around labeling as type 2M were noted.

Confidence intervals do not cross the effect estimates of different studies.

§

Small number of subjects.

Patients incorrectly classified as not having type 2 VWD.

ǁ

Patients without type 2 VWD.

#

Patients incorrectly classified as having type 2 VWD.

or Create an Account

Close Modal
Close Modal